[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.207.106.142. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Original Investigation
July 2013

Effect of Weight Loss on the Severity of Psoriasis: A Randomized Clinical Study

Author Affiliations
  • 1Department of Dermato-Allergology, Copenhagen University Hospital Gentofte, Hellerup, Denmark
  • 2Department of Clinical Nutrition, Copenhagen University Hospital Gentofte, Hellerup, Denmark
  • 3Departments of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital Gentofte, Hellerup, Denmark
  • 4Department of Clinical Biochemistry, Copenhagen University Hospital Gentofte, Hellerup, Denmark
  • 5Department of Cardiology, Copenhagen University Hospital Gentofte, Hellerup, Denmark
  • 6The Parker Institute, Department of Rheumatology, Copenhagen University Hospital Frederiksberg, Frederiksberg, Denmark
  • 7Department of Nutrition, Exercise, and Sports, Faculty of Science, University of Copenhagen, Frederiksberg, Denmark
JAMA Dermatol. 2013;149(7):795-801. doi:10.1001/jamadermatol.2013.722
Abstract

Importance  Psoriasis is associated with adiposity and weight gain increases the severity of psoriasis and the risk of incident psoriasis. Therefore, we aimed to measure the effect of weight reduction on the severity of psoriasis in obese patients with psoriasis.

Objective  To assess the effect of weight reduction on the severity of psoriasis in overweight patients.

Design  Sixty obese patients with psoriasis from our dermatology outpatient clinic were enrolled in a prospective randomized clinical trial in which they were allocated to a control group or an intervention group.

Setting  University hospital outpatient dermatology clinic.

Participants  We included 60 of 69 eligible overweight patients with psoriasis (body mass index [calculated as weight in kilograms divided by height in meters squared], 27-40; aged 25-71 years).

Interventions  The intervention group received a low-energy diet (LED) (800-1000 kcal/d) for 8 weeks to induce weight loss, followed by 8 weeks of reintroduction of normal food intake, reaching 1200 kcal/d. The control group was instructed to continue eating ordinary healthy foods.

Main Outcomes and Measures  Psoriasis Area and Severity Index (PASI) after 16 weeks, with Dermatology Life Quality Index (DLQI) as a secondary end point.

Results  The median PASI for all patients was 5.4 (interquartile range, 3.8-7.6) at baseline. At week 16, the mean body weight loss was 15.4 kg (95% CI, 12.3-18.5 kg; P < .001) greater in the intervention group than in the control group. The corresponding mean differences in PASI and DLQI, also in favor of the LED group, were −2.0 (95% CI, 4.1 to −0.1; P = .06) and −2.0 (95% CI, −3.6 to −0.3; P = .02), respectively.

Conclusions and Relevance  Treatment with an LED showed a trend in favor of clinically important PASI improvement and a significant reduction in DLQI in overweight patients with psoriasis.

Trial Registration  clinicaltrials.gov Identifier: NCT01137188

×